Excellence in clinical research from A to Z

Scroll down ⇩

About us

AtoZ-CRO GmbH is a full-service clinical research organisation (CRO) located in Overath near Cologne, Germany, with over 30 years of experience in clinical development and clinical study management. As a specialist for Germany, Europe, the US, and India, AtoZ-CRO offers a broad range of professional services and partner solutions for international clinical studies with pharmaceuticals and medical devices.


From its head office located in Overath, Germany, AtoZ-CRO manages and coordinates clinical studies of phase 0 through phase IV for national and international clients. The company forms a team of 35 highly experienced and dedicated industry professionals and medical specialists ensuring high standards in clinical study management. AtoZ-CRO is affiliated with a leading initiator of phase I studies in Warsaw, Poland.


Based on the company’s long-established international experience in clinical trial management and cooperation with high-rated business partners, AtoZ-CRO is proud to offer a broad range of services covering all clinical research needs, in particular for small and mid-sized pharmaceutical, biotech, and medical device companies.

Clinical Studies 

Contact us

Clinical Studies

Clinical Studies Phases 0 – IV

  • Planning of clinical studies
  • Preparation of study protocols
  • Design and implementation of CRFs (case report forms) and eCRFs
  • Processing of applications for ethical votes and permissions (e.g. CTA, IND)
  • Regulatory affairs issues
  • Legal EU representative

Other services

  • Monitoring
  • Post-marketing studies

-  NIS

-  PASS

-  Epidemiology

  • Pharmacovigilance
  • Biometry
  • Medical Writing and Translations

About us

Contact us

Contact us

AtoZ-CRO GmbH

Hauptstr. 77
51491 Overath
Tel: 02206 95 99 0
Fax: 02206 820 63
Email: info@atoz-cro.de
www.atoz-cro.de

Business Development

Alexa Foltin-Mertgen, M.Sc.
Email: a.foltin-mertgen@atoz-cro.de

Back to top ⇧

Go to article: Home | Advancing adherenceGo to article: Scandinavian Health Company InsightGo to article: Scandinavian Health Ltd.Go to article: EditorialGo to article: PfanstiehlGo to article: Pfanstiehl Company InsightGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: Owen MumfordGo to article: NewsGo to article: TSS Company InsightGo to article: TSS ABGo to article: Novo NordiskGo to article: The pharma industry briefingGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CRO GmbHGo to article: Timeline: using viruses to fight diseaseGo to article: Swiss WorldCargoGo to article: AirBridgeCargo Company InsightGo to article: AirBridgeCargoGo to article: Q&A: an eye on innovation with SparingVisionGo to article: MasterpackGo to article: Molnar Company InsightGo to article: MolnarGo to article: B&W TekGo to article: Could smart pill bottles dispense a solution to drug non-adherence?Go to article: Hapa Company InsightGo to article: Qatar AirwaysGo to article: Dow EuropeGo to article: WHO’s Essential Medicines List: discussing innovation and accessGo to article: Erdmann Design SwitzerlandGo to article: AEB Company Insight Go to article: AEBGo to article: Centaur Clinical | Company InsightGo to article: Centaur ClinicalGo to article: Are we nearing the end of animal testing in pharma?Go to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Barc Lab Go to article: Why is pharma so bad at sharing clinical trial data?Go to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Capsugel Company InsightGo to article: Unseen genes: boosting African DNA in medical researchGo to article: Emirates SkyCargoGo to article: Pfeiffer VacuumGo to article: Could Netflix-style subscription models work for medicines?Go to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: MicronovaGo to article: AlpexGo to article: EventsGo to article: Senn Chemicals Company InsightGo to article: Senn ChemicalsGo to article: ICCI Company InsightGo to article: ICCIGo to article: Next issueGo to article: CBDepot Company InsightGo to article: CBDepotGo to article: Nemera Company InsightGo to article: NemeraGo to article: Komtur Pharmaceuticals Company InsightGo to article: Komtur PharmaceuticalsGo to article: MimotopesGo to article: Baxter